News

News

Tzield for Recently Diagnosed Stage 3 Type 1 Diabetes: What Families Should Know

FDA granted accelerated approval for Tzield in children ages 8 to 17 recently diagnosed with...

Tirzepatide Maintenance Study: What SURMOUNT-MAINTAIN Means

Plain-language SURMOUNT-MAINTAIN summary covering continued tirzepatide, dose reduction, weight regain, study limits, and patient questions...

The Unseen Epidemic: Unpacking Global Diabetes Statistics

The Unseen Epidemic: Unpacking Global Diabetes Statistics: evidence-based guidance reviewed against current NICE and ADA...

Retatrutide: A New Horizon in Diabetes and Obesity Management

Retatrutide: A New Horizon in Diabetes and Obesity Management: evidence-based guidance reviewed against current NICE...
Spread the love